🌟 Thanks to all at #ESTRO24 ! With 7,046 participants, it's been our biggest congress yet! Grateful for your contributions to #radiotherapy & #radiationoncology . Here's to continued collaboration! See you in Vienna 2025! 🙌

Congratulations Anna Kirby Anthony Chalmers 💙 all contributing colleagues and ESTRO staff for an inspiring #ESTRO24 💪

Looking forward to #ESTRO25 in beautiful Vienna:
👉 „Transformative Innovation through Partnership“

Alpha-Fold 3. The rate of advances in AI driven biological discovery continues to increase. Exciting.

Check out this new award opportunity for #radonc residents and medical students!

ROI is thrilled to be working with ARRO to accept nominations in conjunction with our 2024 Publication Excellence Awards. Nominations for both are due July 5.

Helen Shih, MD, medical director for the Proton Therapy Centers, discusses the effectiveness of proton therapy treatment for brain tumors and why it is important to choose a care team with proven expertise.
spklr.io/6012o4Bw #BrainTumorAwarenessMonth

Drew Hope from Radiation Medicine Program Princess Margaret Cancer Centre @uhn Radiation Oncology leads off the final debate with a great argument for increasing AI and automation in #radonc in Glasgow #ESTRO24 in style in a kilt!

Congratulations to @ESTRO Anna Kirby Anthony Chalmers 💙 for a record-breaking, breathtaking, stimulating, earth-shaking #ESTRO2024 . Enjoyed Scotland, the hospitality, the networking, and all the science. 🙏🏽🏴󠁧󠁢󠁳󠁣󠁴󠁿🙏🏽🏴󠁧󠁢󠁳󠁣󠁴󠁿

Congratulations prof. Barbara Jereczek-Fossa, as president-elect and Matthias Guckenberger as new president of ESTRO. Thanks Anna Kirby for leading the society in the past 2 years.

In Memoriam: C. Norman Coleman, M.D. (1945–2024)

Touching and inspiring homage in Radiotherapy & Oncology 🙏

Michael Baumann, MD Pierre Blanchard, MD
National Cancer Institute NCI CTEP Clinical Research

➡️thegreenjournal.com/article/S0167-…

Anthony Chalmers 💙 receives the #ESTRO24 Interdisciplinary Award - a life of multidisciplinary collaboration. 👏🏽👏🏽👏🏽🤩 An emotional moment, indeed. ESTRO The Royal College of Radiologists

#ESTRO24 Piet Ost presenting outcomes of STORM randomized Ph II of MDT v ENRT for oligorecurrent prostate cancer #pcsm

✅ ENRT ⬆️BRFS, LRFS

MDT a/w 8-fold ⬆️ nodal recurrence 3➡️25%

Omitting PB ⬆️ local recurrences 3-fold (5➡️14%), but also increases GU2+ toxicity

I second that ‼️😊🙏🙏🙏
Randall Kimple Nicole Simone Pippa Cosper MD, PhD Gaorav Gupta Steven H. Lin Deborah Citrin BioActinideChemistry David Kirsch, MD, PhD Brad Wouters 🇨🇦 Marianne Koritzinsky Laure Marignol Heiko Enderling, PhD, FSMB Karl Butterworth Nadeem Riaz Timothy Chan Terry Williams Sonja Dieterich, Ph.D., MBA…

Learned lots from fellow speakers at this session!

Great to connect with global leaders in #radiopharmaceuticals !

Many thanks to Drs. Michalski and Kirby for making this session happen!

#ESTRO24 Jeff Michalski Prof Joe O'Sullivan ESTRO ASTRO

Absolute tour-de-force through the history and current understanding of dose, fractionation and time effects in clinical radiotherapy by Søren M Bentzen #ESTRO24 I don’t think I’ve ever seen so many people turn out for an 8am lecture - and we were in for a treat! #medphys #radonc

Really looking forward to Anthony Chalmers 💙 award lecture at 14.15 today
👏well deserved ESTRO multidisciplinary award #ESTRO24

This study highlights the power of PROMs #ESTRO24
▶️Clinicians consistently underestimate treatment-related toxicity
▶️ Proud that The Christie NHS hosts one of the most extensive ePROM oncology programs within routine clinical practice
James Price Janelle Yorke

Excellent comment Michael MacManus
For those interested in this topic ▶️ please read this review by the IASLC ART committee ‘Treatment response biomarkers: working towards personalised radiotherapy for lung cancer’ JTO & JTO CRR Ash The Christie NHS
doi.org/10.1016/j.jtho…

The CONCORDE early phase platform of DDRi and RT combination highlighed by ⁦⁦Andrea R. Filippi⁩ in the ⁦IASLC⁩ ⁦ESTRO⁩ session
▶️multiarm/multidrugs
▶️efficient Bayesian design
▶️control arm RT alone
⁦⁩ ⁦⁦Leeds CTRU⁩ ⁦Science and Innovation at Cancer Research UK⁩

Gerry Hanna Corinne Faivre-Finn 💙 BTOG Patrick Forde Jarushka Naidoo Michael MacManus Matthias Guckenberger Fiona McDonald Nikki P Filippo Alongi Andrea R. Filippi It is more than appropriate to revisit the optimal RT dose which was established >40 years ago - before concurrent systemic therapies were introduced.

Alright, so this cannot be emphasized enough‼️

📢Local failure almost always occurs in tumors/nodes > 3-4 cm⚠️

Because. 60 Gy. Is. Not. Enough.
#radbio 1⃣ 0⃣ 1⃣

(also, nobody treats a 4 cm HNSCC with 60 Gy+chemo💡)

#ESTRO24 #LCSM

Andrea R. Filippi Terry Williams David Sher